Stock events for Lifestance Health Group, Inc. (LFST)
LifeStance Health Group's stock has been influenced by earnings reports and market movements. The company reported positive Q3 2025 results, exceeding revenue expectations and achieving a net income, along with strong organic visit growth and an increased clinician team. Earlier, the company reported a loss for Q2 2025 but still managed to top revenue estimates. Despite some positive earnings news, the company's share price experienced a decline. Daily stock movements have shown some volatility, influenced by broader market trends and investor sentiment. The next earnings report is anticipated around February 26, 2026.
Demand Seasonality affecting Lifestance Health Group, Inc.’s stock price
The provided information does not explicitly detail specific demand seasonality for LifeStance Health Group's services. However, the broader mental healthcare industry is experiencing rising demand, driven by factors such as an aging population, an increasing prevalence of chronic diseases, and a shift towards value-based care models.
Overview of Lifestance Health Group, Inc.’s business
LifeStance Health Group, Inc. provides outpatient mental healthcare services in the United States, offering a range of services for various age groups, including psychiatric evaluations, psychological testing, and therapy. The company addresses mental health conditions like anxiety, depression, and PTSD, operating through a hybrid care delivery model with both virtual and in-person services.
LFST’s Geographic footprint
LifeStance Health Group, Inc. is headquartered in Scottsdale, Arizona, and operates in 33 states with more than 550 centers across the United States.
LFST Corporate Image Assessment
LifeStance Health Group has engaged in activities that contribute to its brand reputation, such as presenting at industry events and partnering with Calm Health to improve access to mental health care. The company's financial performance, including beating revenue expectations and reducing losses in Q3 2025, can positively impact its reputation. However, some analyst reports have expressed reservations.
Ownership
LifeStance Health Group, Inc. is predominantly owned by institutional shareholders, holding approximately 85.50% to 89.97% of the company's stock. TPG Group Holdings SBS Advisors Inc. is the largest individual shareholder. Retail investors hold a negligible percentage of the stock.
Ask Our Expert AI Analyst
Price Chart
$7.25